In this episode, I conclude our series on the USMLE Step 1 Free 120. Lots of useful nuggets and learning across this series. As I have mentioned earlier, strongly consider listening to all the episodes in order as a good form of prep after you take the test with the PDF. Audio Download
Nov 27
December 2025 Step 1-3 USMLE/COMLEX Classes (including 25 Hour Step 1 Review from 12/1-5)
In this podcast, I explain exactly what you should expect to get from all my classes. I go over each class and discuss the way they are structured, specific advantages offered by each class, and my approach to covering the material. I discuss differences between the classes and m ... Show More
26m 51s
Nov 22
25 Hour Step 1 Basic Science Review (12/1-5, 2025)
In this short podcast, I discuss the upcoming 25 Hour USMLE Step 1 Basic Science Review taking place on zoom from 6-11 pm EST from 12/1-5. The review will be incredibly clinical, focus on integrations, help you understand pathophysiology, and expose you to a large amount of the S ... Show More
6m 18s
Sep 2023
Episode 073: Management of Early Stage Diffuse Large B-Cell Lymphoma (DLBCL)
<p class="" style="white-space:pre-wrap;">This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease. </p><p class="" style="white-space:pre-wrap;">If you have not done so, we highly recommend you listen to our ... Show More
29m 17s
May 2025
Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ... Show More
25m 58s
Dec 2024
Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML
<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transp ... Show More
26m 12s
Feb 2022
Episode 007: Heme Path Capstone Pt. 2
<p class="" style="white-space:pre-wrap;">Heme Path Capstone Pt. 2 Pearls</p><p class="" style="white-space:pre-wrap;">In this episode, we continue our conversation with guest, Dr. Emily Mason, hematopathologist at Vanderbilt University Medical Center (Nashville, TN), as we apply ... Show More
32m 34s
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More
36m 11s
<p>In Part 3 of our Heme Path series, we break down the basics of immunohistochemistry (IHC)</p><p>Episode contents: </p><p>- What is immunohistochemistry? </p><p>- What are the pros and cons? </p><p>- How do we use this clinically? </p><p>****Have some time and want to make some ... Show More
<p>In Part 2 of our Heme Path series, we get into the details of cytogenetics (conventional karyotype and FISH)</p><p>Episode contents: </p><p>- What is "cytogenetics"? </p><p>- How do we use cytoenetic information clinically? </p><p>- What is the difference between the conventio ... Show More
<p class="" style="white-space:pre-wrap;">Heme Path Capstone Pt. 1 Pearls</p><p class="" style="white-space:pre-wrap;">It’s time to put all you have learned in our Heme Path series to the test! Listen in as our guest, Dr. Emily Mason, hematopathologist at Vanderbilt University Me ... Show More
<p class="" style="white-space:pre-wrap;">This week, we continue our conversation about DLBCL, this time focusing our attention on the management of early stage disease. </p><p class="" style="white-space:pre-wrap;">In this week’s episode, we delve into the management of advance ... Show More
